Natural disease course of inflammatory bowel disease unclassified in a prospective European population-based inception cohort-the Epi-IBD cohort

J. Burisch , P. Ellul (1) , N. Arebi , I. Kaimakliotis , R. d'Inca , V. Andersen , E. Belousova , V. Hernandez , Z. Vegh , S. Turcan , F. Magro (2) , L. Kupcinskas , J. Halfvarson , P. L. Lakatos (3) , Dana Duricova (4) , L. Kievit , A. Goldis , J. F. Dahlerup , P. Oksanen , S. Cukovic-Cavka , Mathurin Fumery (4, 5) , S. Odes , K. R. Nielsen , D. Valpiani , N. Pedersen , M. Giannotta , R. Salupere , K. H. Katsanos , E. Langholz , P. Munkholm , Epi-Ibd Study Grp

1 CGIAR - Consultative Group on International Agricultural Research [CGIAR]
2 Hospital de São João [Porto]
3 Semmelweis University [Budapest]
4 CHU Amiens-Picardie
5 PERITOX - Périnatalité et Risques Toxiques - UMR INERIS_I 1

Domaines: Sciences du Vivant [q-bio]

J. Burisch, P. Ellul, N. Arebi, I. Kaimakliotis, R. d'Inca, et al.. Natural disease course of inflammatory bowel disease unclassified in a prospective European population-based inception cohort-the Epi-IBD cohort. Journal of Crohn's and Colitis, 2018, 12 (1), pp.S523-S524. ⟨hal-03552410⟩